Revenue (Tables)

12 Months Ended

Dec. 31, 2023

Disaggregation of Revenue [Abstract]

Schedule of Revenue Disaggregated by Customer Type

The following table presents revenue disaggregated by customer type (in thousands):


		Year Ended December 31,
		2023				2022				2021
Pharma tests and services		$	31,904			$	29,552			$	30,282
Enterprise sales			31,729				26,641				8,774
Population sequencing			9,412				8,443				45,671
Other			436				411				767
Total revenue		$	73,481			$	65,047			$	85,494

Schedule of Contract Assets and Liabilities

The opening and closing balances of receivables and contract liabilities from contracts with customers are shown below (in thousands). Contract assets were immaterial for all periods presented.


		December 31,
		2023				2022
Opening balances:
Accounts receivable, net		$	16,642			$	18,468

Short-term contract liabilities		$	1,264			$	3,982
Long-term contract liabilities (included in other long-term liabilities)			—				—
Total contract liabilities			1,264				3,982

Closing balances:
Accounts receivable, net		$	17,730			$	16,642

Short-term contract liabilities		$	3,288			$	1,264
Long-term contract liabilities (included in other long-term liabilities)			3,928				—
Total contract liabilities			7,216				1,264